Outpace Bio Revenue and Competitors
Estimated Revenue & Valuation
- Outpace Bio's estimated annual revenue is currently $5.3M per year.
- Outpace Bio's estimated revenue per employee is $77,500
- Outpace Bio's total funding is $30M.
Employee Data
- Outpace Bio has 68 Employees.
- Outpace Bio grew their employee count by 24% last year.
Outpace Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder, CEO | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | CSO | Reveal Email/Phone |
4 | Human Resources Director | Reveal Email/Phone |
5 | Associate Director, Business Operations | Reveal Email/Phone |
6 | Director Financial Planning and Analysis | Reveal Email/Phone |
7 | Senior Director - CAR T Pipeline | Reveal Email/Phone |
8 | Associate Director, Immunology | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Director, Synthetic Biology and Biophysics | Reveal Email/Phone |
Outpace Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Outpace Bio?
$30M
Total Funding
68
Number of Employees
$5.3M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Outpace Bio News
... two leases have been signed with Shape Therapeutics taking around 137,900 square feet and Outpace Bio renting nearly 23,100 square feet.
He's now founder of Sci.bio, a Boston-area biopharma recruitment and executive search firm ... scientists and other biopharma workers to outpace supply.
Outpace Bio CEO (Outpace Photo) New funding: Outpace Bio raised a $30 million Series A investment round to design custom cell and gene-based therapies. The science: Founded in November, the Seattle startup is developing software and hardware to manipulate how cells interact with diseases. Its ...
Outpace Bio, a Seattle, WA-based biotechnology company building a platform to create next-generation smart cell therapies, closed a $30m Series A financing round. The round was led by Artis Ventures and Lyell Immunopharma, Inc., with participation from Abstract Ventures, Civilization Ventures, ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.7M | 68 | 19% | $14.5M |
#2 | $16.5M | 68 | -7% | N/A |
#3 | $7.7M | 68 | -32% | $82.3M |
#4 | $5M | 68 | -3% | N/A |
#5 | $9.9M | 68 | 15% | N/A |